Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine vs Saline Post-TURBT for Low-Grade Bladder Cancer
NCT00445601Phase 3Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Sep 2007
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine in bladder cancer, sponsored by SWOG Cancer Research Network. Started Sep 2007; status: completed.
02
Drugs
gemcitabine
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00445601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445601.